Clincosm LogoSign in Get a demo

primary sjögren's syndrome

Showing 1 - 25 of 31
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Sjögren's Syndrome Trial (Efgartigimod, Placebo)

Not yet recruiting
  • Primary Sjögren's Syndrome
  • Efgartigimod
  • Placebo
  • (no location specified)
Apr 5, 2023

Primary Sjogren's Syndrome Trial (LY3361237)

Not yet recruiting
  • Primary Sjogren's Syndrome
  • (no location specified)
Mar 20, 2023

Primary Sjögren's Syndrome Trial in Worldwide (S95011 concentrate for solution for infusion, Placebo concentrate for solution

Active, not recruiting
  • Primary Sjögren's Syndrome
  • S95011 concentrate for solution for infusion
  • Placebo concentrate for solution for infusion
  • Beverly Hills, California
  • +27 more
Jan 13, 2023

Primary Sjogren's Syndrome Trial in China (Telitacicept 80 mg, Telitacicept 160 mg, Placebo)

Not yet recruiting
  • Primary Sjogren's Syndrome
  • Telitacicept 80 mg
  • +2 more
  • Bengbu, Anhui, China
  • +67 more
Jan 5, 2023

Autoimmune Disorder, Rheumatoid Arthritis, Systemic Lupus Erythematosus Trial in Worldwide (branebrutinib, abatacept,

Completed
  • Autoimmune Disorder
  • +3 more
  • Phoenix, Arizona
  • +80 more
Dec 16, 2022

Healthy Participants, Primary Sjögren's Syndrome Trial in Berlin (BMS-986325, Placebo for BMS-986325)

Recruiting
  • Healthy Participants
  • Primary Sjögren's Syndrome
  • BMS-986325
  • Placebo for BMS-986325
  • Berlin, Germany
    Local Institution - 0001
Jul 11, 2022

Primary Sjögren's Syndrome Trial in Hangzhou (Iguratimod Tablets, Hydroxychloroquine Sulfate Tablets)

Recruiting
  • Primary Sjögren's Syndrome
  • Iguratimod Tablets
  • Hydroxychloroquine Sulfate Tablets
  • Hangzhou, Zhejiang, China
    Second affiliated hospital of zhejiang university，school of medi
Mar 23, 2022

Primary Sjögren's Syndrome Trial in Beijing (Tofacitinib)

Recruiting
  • Primary Sjögren's Syndrome
  • Beijing, Beijing, China
    Department of Rheumatology and Immunology, Peking University Peo
Feb 28, 2022

Primary Sjogren's Syndrome Trial in Palo Alto (tibulizumab (LY3090106))

Withdrawn
  • Primary Sjogren's Syndrome
  • tibulizumab (LY3090106)
  • Palo Alto, California
    Stanford University
Jan 12, 2022

Primary Sjögren's Syndrome Trial in Yantai (Placebo, RC18 240 mg, RC18 160 mg)

Completed
  • Primary Sjögren's Syndrome
  • Placebo
  • +2 more
  • Yantai, Shandong, China
    Remegen,Ltd.
Jan 7, 2022

The Profile of Fatigue and Discomfort - Sicca Symptoms Inventory

Not yet recruiting
  • Primary Sjögren's Syndrome
  • Patients group
  • Çankaya, Ankara, Turkey
    Gazi University
Oct 5, 2021

Primary Sjögren's Syndrome Trial in Berlin (VAY736, Placebo)

Completed
Has Results
  • Primary Sjögren's Syndrome
  • Berlin, Germany
    Novartis Investigative Site
Sep 30, 2021

Turkish Version of Primary Sjögren Syndrome Quality of Life

Recruiting
  • Primary Sjögren's Syndrome
  • Survey study
  • Ankara, Turkey
    Gazi University
Aug 31, 2021

Primary Sjögren's Syndrome Trial in United States (Parsaclisib)

Completed
Has Results
  • Primary Sjögren's Syndrome
  • Miami, Florida
  • +3 more
Aug 11, 2021

Autoreactive Anti-Ro/SSA IgE To Determine Primary SjögRen's

Recruiting
  • Primary Sjögren's Syndrome
  • Blood samples
  • Bourgoin-Jallieu, France
  • +7 more
Jul 23, 2021

Primary Sjogren's Syndrome, Interstitial Lung Disease Trial in Shanghai (Jianfei Kangfu Cao, lung rehabilitation training)

Recruiting
  • Primary Sjogren's Syndrome
  • Interstitial Lung Disease
  • Jianfei Kangfu Cao
  • lung rehabilitation training
  • Shanghai, Shanghai, China
    Longhua Hospital Affiliated to Shanghai University of Traditiona
Feb 24, 2021

Primary Sjögren's Syndrome Trial in Worldwide (CFZ533 active - Cohort 1, CFZ533 - Cohort 1, CFZ533 active - Cohort 2)

Completed
Has Results
  • Primary Sjögren's Syndrome
  • CFZ533 active - Cohort 1
  • +5 more
  • Boston, Massachusetts
  • +8 more
Dec 9, 2020

Primary Sjögren's Syndrome Trial in Berlin, Debrecen (CDZ173, Placebo)

Completed
Has Results
  • Primary Sjögren's Syndrome
  • Berlin, Germany
  • +1 more
Dec 9, 2020

Primary Sjögren's Syndrome Trial in Worldwide (UCB5857, Placebo)

Terminated
  • Primary Sjögren's Syndrome
  • Brest, France
  • +13 more
Nov 26, 2020

Primary Sjögren's Syndrome Trial in Le Kremlin Bicêtre (No intervention)

Recruiting
  • Primary Sjögren's Syndrome
  • No intervention
  • Le Kremlin Bicêtre, Val De Marne, France
    Hopital Bicêtre
Mar 12, 2020

Ultrasound Abnormalities of Salivary Glands in Primary Sjögren's

Unknown status
  • Primary sjögren's Syndrome
    • Brest, France
    • +2 more
    Dec 26, 2019

    Primary Sjögren's Syndrome Trial in Worldwide (AMG 557/MEDI5872, Placebo)

    Completed
    Has Results
    • Primary Sjögren's Syndrome
    • AMG 557/MEDI5872
    • Placebo
    • San Francisco, California
    • +12 more
    Feb 27, 2019

    Primary Sjögren's Syndrome Trial in United States (Baminercept, Placebo)

    Terminated
    Has Results
    • Primary Sjögren's Syndrome
    • Baminercept
    • Placebo
    • Los Angeles, California
    • +8 more
    Dec 31, 2018

    Primary Sjögren's Syndrome Trial in France (skin biopsy)

    Completed
    • Primary Sjögren's Syndrome
    • skin biopsy
    • Albi, France
    • +6 more
    Jan 10, 2019

    Primary Sjögren's Syndrome Trial in Beijing (hrIL-2 active, hrIL-2 )

    Completed
    • Primary Sjögren's Syndrome
    • hrIL-2 active
    • hrIL-2 placebo
    • Beijing, Beijing, China
      Department of Rheumatology and Immunology, Peking University Peo
    Mar 13, 2018